Delivery Order SPE2DB24D9131-SPE2DB24FXRL2
- Not listed
- This federal contract award, valued at $18,488.12, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product Trikafta, a specialized medication used to treat cystic fibrosis. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure...
- This federal contract award, valued at $111,160.98, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB Medical Supply Chain program, which allows the agency to fulfill recurring pharmaceutical and medical supply needs of military health facilities worldwide. This award is part of a larger $499,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,805.57 firm fixed-price delivery order is for the supply of Trikafta, a specialized pharmaceutical product used to treat cystic fibrosis. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- This federal contract award, valued at $18,526.83, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of a pharmaceutical product called TRIKAFTA 100-50-75 MG/150 MG UU 84S. This award is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
- This federal contract award, valued at $74,107.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product Trikafta, which is used for the treatment of cystic fibrosis. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
- The federal contract award is valued at $55,580.49 and was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA. This single-award IDC, under the SPE2DB program, allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $18,526.83, is a firm fixed-price delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This IDC allows the DLA to order a comprehensive range...
- This federal contract award, valued at $36,656.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to provide the specialized medication Trikafta, a treatment for cystic fibrosis. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the specialized medication Trikafta, which is used to treat cystic fibrosis. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,053.68 firm fixed-price delivery order is for the supply of Trikafta 100-50-75 mg/75 mg packets, a critical cystic fibrosis medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB24FXRL2Delivery Order
This federal contract award, valued at $18,526.83, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product TRIKAFTA, a specialty drug used to treat cystic fibrosis. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation, and DMS Pharmaceutical Group's status as a woman-owned small business has enabled it to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 6/3/24 |